To hear about similar clinical trials, please enter your email below
Trial Title:
Navigating the Clinical Research Process for Glioma
NCT ID:
NCT05958472
Condition:
Glioma
Conditions: Official terms:
Glioma
Conditions: Keywords:
glioma
Study type:
Observational
Overall status:
Not yet recruiting
Study design:
Time perspective:
Prospective
Summary:
Participation in medical trials usually favors a particular demographic group. But there
is limited research available to explain what trial attributes affect the completion of
these specific demographic groups.
This trial will admit a wide range of data on the clinical trial experience of glioma
patients to determine which factors prevail in limiting a patient's ability to join or
finish a trial.
It will also try to analyze data from the perspective of different demographic groups to
check for recurring trends which might yield insights for the sake of future glioma
patients.
Criteria for eligibility:
Study pop:
Glioma patients who are actively considering participating in a clinical trial, but have
not yet completed enrollment and randomization.
Sampling method:
Probability Sample
Criteria:
Inclusion Criteria:
- Confirmed diagnosis of glioma
- Participant must be 18 years of age or older
- Participant must be willing and able to comply with scheduled visits, treatment
schedule, laboratory tests, and other requirements of the study.
Exclusion Criteria:
- Pregnant or lactating woman
- Participant is actively receiving study therapy in another
- Inability to provide written informed consent
Gender:
All
Minimum age:
18 Years
Maximum age:
N/A
Healthy volunteers:
No
Locations:
Facility:
Name:
Power Life Sciences
Address:
City:
San Francisco
Zip:
94107
Country:
United States
Contact:
Last name:
Michael B Gill
Phone:
415-900-4227
Email:
https://www.withpower.com/contact-us@withpower.com
Start date:
August 2024
Completion date:
August 2026
Lead sponsor:
Agency:
Power Life Sciences Inc.
Agency class:
Industry
Source:
Power Life Sciences Inc.
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT05958472
